<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01094106</url>
  </required_header>
  <id_info>
    <org_study_id>NCCHAne001</org_study_id>
    <nct_id>NCT01094106</nct_id>
  </id_info>
  <brief_title>Infiltration Analgesia After Caesarean Section</brief_title>
  <official_title>Local Infiltration Analgesia for Postoperative Pain After Caesarean Section. A Prospective, Randomised, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>North Karelia Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>North Karelia Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infiltration of a local anesthetic into the surgical wound is a simple method to strive to
      control postoperative pain after surgery. In the investigators institution, this method is
      used quite often. However, there is a controversy regarding the analgesic efficacy. Moreover,
      the cost of the single use elastomeric pump used with this procedure is clearly higher than
      the costs of other routinely used analgesic methods.

      According to the investigators observations, infiltration of a local anesthetic into the
      surgical wound after caesarean section seems to reduce the need for rescue analgesics.
      However, the scientific evidence of the efficacy of this technique is weak. The investigators
      decided to conduct a prospective, controlled, randomised, double blind trial on this topic.

      The hypothesis is that wound infiltration with local anesthetic will reduce postoperative
      pain and opioid consumption after caesarean section without major adverse effects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The demand of rescue analgesics</measure>
    <time_frame>48 hours</time_frame>
    <description>The amount of opiate analgesics requied 48 hours after operation. Rescue analgesics will be administred when the strength of pain is over 3 on numeric rating scale (NRS) 0-10.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Strength of pain on numeric rating scale (NRS)</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting (PONV)</measure>
    <time_frame>48 hours</time_frame>
    <description>The vigor of nausea will be assessed on the numeric rating scale (NRS) 0-10. NRS values over 3 will be medicated with antiemetics.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Caesarean Section</condition>
  <arm_group>
    <arm_group_label>Ropivacaine 0,75%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Postoperative wound infusion 15 mg /h / 48h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NaCl 0,9%</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Postoperative wound infusion with NaCl 0,9% 2 ml /h /48h</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0,75%</intervention_name>
    <description>Postoperative wound infusion 2 ml/ h/ 48h</description>
    <arm_group_label>Ropivacaine 0,75%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NaCl 0,9%</intervention_name>
    <description>Postoperative wound infusion 2 ml/h/48h</description>
    <arm_group_label>NaCl 0,9%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  volunteer

          -  age over 18 years

          -  spinal anesthesia

          -  ASA 1-2

          -  no allergy to used medications

          -  no medications which have effect on pain perception

        Exclusion Criteria:

          -  patient`s refusal to participate

          -  marked systemic disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sakari Syv√§oja, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>North Carelia CH, Department of Anesthesia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>North Karelia Central hospital</name>
      <address>
        <city>Joensuu</city>
        <zip>80880</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2010</study_first_submitted>
  <study_first_submitted_qc>March 25, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2010</study_first_posted>
  <last_update_submitted>January 1, 2012</last_update_submitted>
  <last_update_submitted_qc>January 1, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 4, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>North Karelia Central Hospital</investigator_affiliation>
    <investigator_full_name>Sanna Kouhia</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>postoperative pain</keyword>
  <keyword>infiltration analgesia</keyword>
  <keyword>ropivacaine</keyword>
  <keyword>Caesarean Section</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

